Loading...
Cipla Community
NSEI:CIPLA Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 38 Fair Values set on narratives written by author
Community Investing Ideas
Emerging Markets And Chronic Therapies Will Open New Horizons
Key Takeaways Expansion in chronic therapies and complex generics, combined with digital and e-pharmacy investments, drives sustainable revenue and margin growth across key global markets. Manufacturing self-reliance and compliance strengths position Cipla to capitalize on supply chain shifts and localization trends, supporting long-term profitability and export growth.Read more
0users have liked this narrative
0users have commented on this narrative
25users have followed this narrative
AN
₹1.68k
9.9% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
8.36% p.a.
Profit Margin
15.92%
Future PE
34.88x
Share price in 2028
₹2.4k
